News

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, Canada, January 12, 2016; Medgold Resources Corp. (TSX-V: MED) announces that management has determined that it is in the best interests of the Company to extend the expiry date of certain previously issued private placement warrants. Accordingly, subject to TSX Venture Exchange acceptance, the Company intends to extend the expiry date of outstanding warrants to purchase up to 9,550,000 common shares at $0.15 per share by one year to February 4, 2017, and outstanding warrants[…]

Vancouver, Canada, January 11, 2016; Medgold Resources Corp. (TSX-V: MED) (the “Company” or “Medgold”) is pleased to announce that Medgold has expanded its joint venture with Centerra Gold Inc. (“Centerra”) to include its Boticas and Chaves gold exploration licences. The two licences will be added to the existing joint-venture agreement currently covering the Valongo Belt licences. Dan James, President of Medgold, said: “We are very pleased to announce that we’ve amended our joint venture agreement with Centerra to include the Boticas and Chaves licences in Portugal. We’ve enjoyed a good working[…]

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, Canada, October 14, 2015, Medgold Resources Corp. (TSX-V: MED) (the “Company”) is pleased to announce that it has completed its non-brokered private placement financing of 5.0 million units at $0.10 per unit, for proceeds of $500,000. Each unit consists of one common share and one warrant entitling the holder to purchase one additional common share of the Company at $0.15 for two years from closing. The units are subject to resale restrictions until January[…]

Vancouver, Canada, October 5, 2015, Medgold Resources Corp. (TSX-V: MED) (the “Company”) announces that in accordance with the Company’s agreement to issue up to 435,520 common shares of the Company to Dan James in part consideration for his ongoing services as the Company’s President (see Medgold news release February 19, 2015), the third installment of 108,880 shares has been issued to Mr. James for services rendered during the three months ended September 30, 2015. The shares have a resale restriction which expires on February 1, 2016. About Medgold Medgold is aiming[…]

Vancouver, Canada, September 28, 2015, Medgold Resources Corp. (TSX-V: MED) (the “Company” or “Medgold”) is pleased to announce that the second phase of drilling at the Lagares project in northern Portugal, targeting the Serra da Quinta prospect, is now complete. The drilling cut multiple zones of intense mineralization, including a best interval of 13.77 metres at 2.03 g/t Au. Centerra Gold Inc. (“Centerra”) has an option to earn a 51% interest in the project by spending US$3 million over 3 years at Lagares, and can earn an additional 19% by[…]